Hemab Therapeutics Holdings, Inc. (COAG)
39.40
-0.48
(-1.20%)
USD |
NASDAQ |
Sep 11, 16:00
39.47
+0.07
(+0.18%)
After-Hours: 20:00
Hemab Therapeutics Holdings Total Liabilities (Quarterly) : 13.51M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 13.51M |
| Date | Value |
|---|---|
| March 31, 2026 | 373.88M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Apogee Therapeutics, Inc. | 141.21M |
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.661B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 467.78M |
| Shareholders Equity (Quarterly) | 454.27M |
| Debt to Equity Ratio | 0.0023 |
| Current Ratio | 35.85 |
| Net Debt Paydown Yield | 1.74% |